Beta Bionics Announces Upcoming Investor Conferences Participation
Beta Bionics, Inc. (NASDAQ: BBNX), a trailblazer in diabetes management technology, is set to present at two major investor conferences in the near future. This includes a chance for investors and healthcare professionals to engage with the company and learn more about its innovative solutions aimed at improving the lives of those living with diabetes.
Details of the Conferences
Management will participate in the Wolfe Research 7th Annual Healthcare Conference on a Tuesday in mid-November at 2:00 PM. Following that, they will also present at the Piper Sandler 37th Annual Healthcare Conference on a Tuesday in early December at 4:30 PM.
Webcast Availability
Both presentations will be accessible via live webcast, allowing interested parties to tune in from anywhere. The webcasts will be available on the company's website within the "Investors—Events & Presentations" section and will be archived for replay post-event.
About Beta Bionics
Founded to address the complex needs of insulin-requiring diabetes patients, Beta Bionics, Inc. specializes in designing and developing state-of-the-art medical devices. Their technology includes the iLet Bionic Pancreas, the first FDA-cleared insulin delivery solution that autonomously calculates insulin doses, specifically tailored to enhance the health and quality of life for those managing diabetes.
Innovative Technology Impact
The iLet system leverages advanced closed-loop algorithms to ensure better management of insulin delivery, which significantly benefits a broad population of people requiring insulin. This innovation positions Beta Bionics as a frontrunner in diabetes treatment and technology.
Investor Relations Contact
For more information regarding Beta Bionics’ innovations or to discuss investment opportunities, reach out to Blake Beber, Head of Investor Relations. You can also connect via email for inquiries.
Further Communications
Inquiries regarding media can be directed to Karen Hynes, Vice President of Marketing. The team at Beta Bionics is eager to connect with those interested in their groundbreaking work in diabetes management.
Frequently Asked Questions
What is Beta Bionics known for?
Beta Bionics is recognized for developing advanced diabetes management solutions like the iLet Bionic Pancreas.
When are the investor conferences?
The Wolfe Research conference is on a Tuesday in mid-November, and the Piper Sandler conference is on a Tuesday in early December.
How can I access the conference presentations?
Presentations will be available through live webcasts on the company's investor relations website.
Who can I contact for investor relations inquiries?
Blake Beber is the contact for investor relations at Beta Bionics for any inquiries regarding their innovations.
Where can I learn more about their products?
You can visit the official website of Beta Bionics to explore their innovative products and solutions for diabetes management.